Suchergebnisse - "Gabor, Julian J"

PubPharm (20)

1

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

enthalten in: bioRxiv.org | 2021

von Kremsner, P. | Mann, P. | Bosch, J. | +18

2

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial

enthalten in: Wiener klinische Wochenschrift | 2021

von Kremsner, P. | Mann, P. | Kroidl, A. | +56

3

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

enthalten in: Wiener klinische Wochenschrift | 2021

von Kremsner, P. | Mann, P. | Kroidl, A. | +19

4

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

enthalten in: Wiener klinische Wochenschrift | 2021

von Kremsner, P. | Mann, P. | Kroidl, A. | +19

5

A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Gabor, J. | Kreidenweiss, A. | Weber, S. | +21

6

Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine : Results from a phase II, randomized, multicenter trial

enthalten in: Clinical immunology (Orlando, Fla.) | 2016

von Leroux-Roels, G. | Marchant, A. | Levy, J. | +21

7

Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants

enthalten in: The American journal of tropical medicine and hygiene | 2015

von Gabor, J. | Schwarz, N. | Esen, M. | +2

8

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine : a phase III, randomized trial in adults aged ≥18 years

enthalten in: BMC infectious diseases | 2013

von Kieninger, D. | Sheldon, E. | Lin, W. | +12

9

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

enthalten in: BMC infectious diseases | 2013

von Kieninger, D. | Sheldon, E. | Lin, W. | +12

10

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

enthalten in: BMC infectious diseases | 2013

von Kieninger, D. | Sheldon, E. | Lin, W. | +12